| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,923 |
1,132 |
$374K |
| 97161 |
|
295 |
228 |
$25K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
915 |
869 |
$25K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
801 |
764 |
$21K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
802 |
765 |
$21K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
532 |
464 |
$11K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
396 |
304 |
$9K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,270 |
1,225 |
$8K |
| 80053 |
Comprehensive metabolic panel |
2,107 |
1,871 |
$6K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
64 |
63 |
$6K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
448 |
150 |
$6K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
103 |
27 |
$5K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
94 |
91 |
$4K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,539 |
2,190 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
354 |
162 |
$4K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
370 |
336 |
$3K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
321 |
97 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
933 |
827 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
255 |
242 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
828 |
805 |
$1K |
| 80061 |
Lipid panel |
979 |
952 |
$1K |
| 84439 |
|
586 |
565 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
18 |
13 |
$809.84 |
| 85610 |
|
697 |
328 |
$796.78 |
| 85027 |
|
532 |
462 |
$752.35 |
| 83655 |
|
56 |
46 |
$507.76 |
| 87186 |
|
130 |
115 |
$489.60 |
| 87510 |
|
116 |
107 |
$460.99 |
| 86780 |
|
149 |
141 |
$445.96 |
| 87480 |
|
116 |
107 |
$421.10 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
18 |
17 |
$390.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
128 |
110 |
$358.78 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
39 |
37 |
$354.78 |
| 84702 |
|
98 |
70 |
$323.64 |
| 87276 |
|
53 |
48 |
$321.09 |
| 83550 |
|
113 |
111 |
$233.07 |
| 80164 |
|
121 |
112 |
$219.85 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
16 |
15 |
$195.17 |
| 81001 |
|
187 |
154 |
$187.21 |
| 87275 |
|
53 |
48 |
$176.60 |
| 86901 |
|
134 |
87 |
$160.30 |
| 86900 |
|
157 |
102 |
$158.53 |
| 86850 |
|
151 |
113 |
$148.23 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
72 |
71 |
$133.62 |
| 82950 |
|
153 |
130 |
$124.97 |
| 87660 |
|
116 |
107 |
$114.66 |
| 86765 |
|
37 |
36 |
$111.72 |
| 83540 |
|
117 |
115 |
$108.72 |
| 87340 |
|
42 |
41 |
$85.41 |
| 82570 |
|
74 |
69 |
$81.71 |
| 36415 |
Collection of venous blood by venipuncture |
1,866 |
1,463 |
$79.91 |
| 81002 |
|
30 |
25 |
$25.58 |
| 82728 |
|
24 |
24 |
$24.36 |
| 82947 |
|
17 |
12 |
$18.60 |
| 85651 |
|
12 |
12 |
$13.44 |
| 86592 |
|
14 |
13 |
$3.90 |